Analyst firms · Evercore ISI · NVCR
Evercore ISI NVCR price target and rating history
NovoCure Limited (NVCR) · Health Care
Evercore ISI rates NovoCure Limited (NVCR) Outperform with a $30 price target, as of its latest action on Dec 2, 2024. It has published 4 rating actions on NVCR since January 2022, including 3 upgrades and 1 downgrade.
- Current rating
- Outperform
- Price target
- $30
- Median target, all firms
- Too few
- Actions on NVCR
- 4
Evercore ISI price target on NVCR
Every Evercore ISI rating on NVCR
- Dec 2, 2024
- Jul 31, 2023
- Jul 5, 2022
- Jan 3, 2022
Questions about Evercore ISI and NVCR
- What is Evercore ISI's price target for NVCR?
- Evercore ISI's latest stated price target for NovoCure Limited (NVCR) is $30, from its action on Dec 2, 2024.
- What is Evercore ISI's rating on NVCR?
- Evercore ISI rates NVCR Outperform, a bullish rating, as of Dec 2, 2024.
- When did Evercore ISI last change its view on NVCR?
- On Dec 2, 2024, Evercore ISI upgrades to Outperform from In-line, price target $18 to $30.
More NVCR rating histories
All Evercore ISI ratingsNVCR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.